Unknown OBSERVATIONAL NCT01841905

Detection of Disease-Related Changes in Pre-Symptomatic Alzheimer's Disease (Scope)

Sponsor: Avid Pharmaceuticals

Updated 7 times since 2017 Last updated: Jan 18, 2016 Started: Jul 31, 2013 Primary completion: Dec 31, 2016 Completion: Dec 31, 2016

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A observational or N/A phase clinical study on Alzheimer's Disease, this trial is ongoing. The trial is conducted by Avid Pharmaceuticals and has accumulated 7 data snapshots since 2013. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

Change History

7 versions recorded

Sep 2024 — Present [monthly]

Unknown
Jul 2024 — Sep 2024 [monthly]

Unknown

Status: Unknown Status → Unknown
Jan 2021 — Jul 2024 [monthly]

Unknown Status
Jun 2018 — Jan 2021 [monthly]

Unknown Status
Apr 2018 — Jun 2018 [monthly]

Unknown Status

Phase: NA → None

▶ Show 2 earlier versions

Feb 2018 — Apr 2018 [monthly]

Unknown Status NA

Status: Active Not Recruiting → Unknown Status
Jan 2017 — Feb 2018 [monthly]

Active Not Recruiting NA

First recorded

Jul 2013

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Avid Pharmaceuticals
Heidelberg Engineering, Inc.
Neurotrack
Optovue
Pfizer
Rhode Island Hospital

Data source: Rhode Island Hospital

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Providence, United States